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Purpose: To evaluate the results and complications of exoresection via a partial lamellar 
sclerouvectomy (PLSU) procedure for uveal tumors performed by a novice surgeon without 
help from an experienced surgeon.
Methods: Medical records of 22 patients who underwent exoresection for uveal tumors between 
February 1999 and January 2009 were evaluated retrospectively. Exoresection was considered 
for tumors with their epicenter in the iris or in the ciliary body.
Results: Twenty-two patients with a mean age of 45.9 years (range: 19–72 years) were included 
in this study. The histopathologic diagnosis was uveal malignant melanoma in 16 patients, 
iridociliary nevus in 2 patients, iris nevus in 2 patients, and iridociliary melanocytoma in 
2 patients. Postoperative complications included cataract in 11 patients (50%), scleral thinning in 
4 patients (18%), vitreous hemorrhage in 2 patients (9%), hyphema in 2 patients (9%), secondary 
glaucoma in 2 patients (9%), iridodialysis in 1 patient (4.5%), bullous keratopathy in 1 patient 
(4.5%), and posterior synechiae in 1 patient (4.5%). At a mean follow-up of 40.1 months (range: 
1–98 months), there were no recurrences or metastatic events.
Conclusions: Exoresection seems to be an effective treatment option in selected cases of iri-
dociliary and ciliary body tumors. Novice surgeons with limited training in PLSU should not 
discourage themselves from doing this type of surgery. Several postoperative complications 
inevitably occur and require frequent patient monitoring.
Keywords: uveal melanoma, uveal nevus, iris, ciliary body, choroid, iris nevus, iris melanoma, 
ciliary nevus, ciliary melanoma, choroidal melanoma, ciliochoroidal melanoma, iridociliocho-
roidal melanoma, partial lamellar sclerouvectomy, exoresection
Introduction
The indications for surgical removal of uveal tumors are numerous. Removal is 
indicated for iridociliary tumors of indeterminate pathology that present suspicious 
features, such as pigment seeding, prominent vascularity, and increased thickness 
and size.1,2 It may not be possible to perform fine-needle aspiration biopsy (FNAB) 
of these tumors, especially if they are located in the iridocorneal angle. Moreover, 
different portions of the tumor may harbor different pathologies, so small FNAB 
samples may be misleading.3 Second, iridociliary tumors with documented growth, 
such as leiomyoma and melanocytoma, need to be surgically excised to restore intra-
ocular structure and prevent complications such as lens subluxation and cataract.4 
Growing necrotic iridociliary melanocytomas can cause increase in intraocular pres-
sure (IOP); thus, removal is also necessary to achieve control of IOP and intraocular 
inflammation.5 Third, in developing countries, plaque radiotherapy or proton beam Clinical Ophthalmology 2010:4 60
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radiotherapy for iridociliary melanomas may not be available. 
Plaque radiotherapy requires custom-designed plaques,6,7 and 
proton beam radiotherapy requires complex instrumentation. 
Both treatments may be prohibitively expensive, if they are 
available at all. Surgical resection may provide an alterna-
tive means of tumor control for iris and certain iridociliary 
melanomas under these circumstances. Fourth, thick ciliary 
body and choroidal melanomas require high radiation doses 
to the tumor and surrounding tissues, resulting in severe 
radiation complications. Surgical resection is believed to be 
safer under these circumstances.8
For the reasons outlined above, the ocular oncologist 
should be familiar with the techniques of partial lamellar 
sclerouvectomy (PLSU) and be able to perform this surgery. 
It is generally believed that iridociliary tumors occupying 
less than three clock hours of pars plicata and choroidal 
melanomas less than 15 mm in base diameter are eligible 
for surgical exoresection.9–11 Although certain surgeons at 
worldwide recognized centers have gained wide experience 
with exoresection using PLSU,9–12 many oncology fellowship 
programs do not offer extensive hands-on experience with 
this technique. Thus, many novice surgeons after fellowship 
training with limited experience in exoresection as a first 
surgeon may be reluctant to start doing this type of surgery 
on their own. In this paper, we describe our use of PLSU 
technique in managing 22 cases of uveal tumors. We address 
the potential difficulties of performing the technique and 
describe common complications, as experienced by a novice 
surgeon (KG) starting on his own without assistance of an 
experienced surgeon.
Materials and methods
We reviewed the clinical charts of 22 patients who under-
went exoresection for uveal tumors between February 1999 
and January 2009. Institutional Review Board approval was 
obtained for reviewing and publishing the results. All patients 
included in this study underwent complete ophthalmic 
examination, including visual acuity and IOP measurement, 
biomicroscopy, and dilated fundus examinations via indirect 
ophthalmoscopy. Tumor dimensions, including base diam-
eter and thickness, were determined by indirect ophthal-
moscopy, A and B mode ultrasonography, and ultrasound 
biomicroscopy, depending on tumor location. The decision 
for tumor removal was based on one of the following criteria: 
1) Suspicious iris/iridocorneal angle/iridociliary tumors with 
pigment dispersion, prominent tumor vascularity, tumor base 
diameter 3 mm, and thickness 2 mm on ultrasound biomi-
croscopy (UBM) or documented growth. 2) Iris, iridociliary, 
ciliochoroidal and iridociliochoroidal melanoma diagnosed by 
clinical examination, ultrasonography, UBM, and/or anterior 
segment/fundus photography. We performed exoresection in 
suspected melanoma cases where the epicenter of the tumor 
was in the iris or ciliary body with minimal extension into the 
adjacent choroid. 3) Patient desire to have the intraocular tumor 
removed rather than followed up with observation despite 
absence of compelling evidence for malignancy or growth.
Informed consent was obtained before surgery. The surgical 
procedure in all cases was performed by the same surgeon (KG) 
who after completing his oncology fellowship started doing 
this surgery on his own. The surgical technique has been 
described previously.8,9 Hypotensive general anesthesia was 
used to keep the systemic blood pressure low. A slightly reverse 
Trendelenburg positon was preferred to reduce bleeding. After 
a Williams lid speculum was inserted, a 270° limbal peritomy 
was done. Three rectus muscles around the area of the tumor 
were hooked and isolated with 2/0 silk sutures. If the tumor 
was under one of the rectus muscles, the overlying muscle was 
disinserted using a double-armed 6/0 vicryl suture. Using blunt 
dissection with Steven’s scissors, the conjunctiva and Tenon’s 
fascia were separated away from the globe in the quadrant of 
the tumor. Using bipolar diathermy, episcleral blood vessels 
were cauterized until the bare sclera was exposed.
After the eye was rotated to the side opposite the tumor, 
the margins of the tumor were localized by transillumina-
tion using a bright focal light on the side of the eye exactly 
opposite the tumor. The margins of the tumor on the sclera 
were marked with a marking pencil around the tumor shadow. 
Subsequently, the margins of the anteriorly hinged scleral 
flap positioned 3–4 mm outside this mark were marked on 
the sclera. The shape of the scleral flap was rectangular. With 
a #57 beaver blade, a groove was created to an approximately 
80%–90% thickness of the sclera, and the scleral flap was 
then developed and carried anteriorly to the corneoscleral 
limbus. If the blue color of the underlying choroid was not 
visible, the plane of dissection was gently deepened until 
it could be seen. Any bleeding from emissary vessels was 
controlled with bipolar cautery. If the tumor was in the irido-
corneal angle, its shadow overlapped with the shadow of the 
pars plicata. In this case, the posterior margin of the tumor 
was marked at the posterior boundary of the pars plicata 
and lateral margins were marked according to the projected 
trajectory based on the contour of the iris tumor.
When the scleral flap was fully developed, transillumina-
tion was repeated. The margins of the tumor were outlined 
on the remaining inner scleral tissue with a marking pencil. 
A small circumferential incision using a 15° microsurgical Clinical Ophthalmology 2010:4 61
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knife was then made on the inner scleral fibers about 3 mm 
outside the margins of the tumor. Then, Vannas scissors were 
used to complete the scleral incision until the uveal tract 
was exposed. The uveal tract was cauterized using bipolar 
cautery until blanching and a gray color change of the uveal 
tissue was achieved.
In uveal tumors involving the iris, a 15° microsurgical 
knife was used to create a paracentesis port in the limbus 
approximately 90° from the area of the main incision, and 
viscoelastic was injected into the anterior chamber. The ante-
rior chamber was then entered using a 15° microsurgical knife 
at the center of the flap area, and the corneoscleral incision 
was made laterally with Westcott scissors. For uveal tumors 
not involving the iris, the anterior chamber was not entered. 
In such cases, if there was marked bulging of the uveal tract, 
aspiration of approximately 1 mL of vitreous was achieved 
via a 22-gauge needle inserted into the central vitreous cavity 
through the pars plana. If there was no obvious bulging of 
the uvea, vitreous aspiration was omitted.
Subsequently, the uveal tumor was excised using Vannas 
scissors. The choroidal/ciliary part of the tumor was excised 
first, followed by excision of the iris part if the tumor had an 
iris component. The pupillary rim was spared, if possible. 
Care was taken to leave the underlying retina or, in the case 
of ciliary tumors, the nonpigmented ciliary pigment epithe-
lium intact. The uveal tumor together with the overlying 
scleral fibers was carefully lifted off the surgical field using 
a “no-touch technique” to avoid spilling tumor cells into the 
surgical field. If vitreous loss occurred, vitreous was removed 
with a vitrectomy instrument. Before doing vitrectomy, three 
to five 9-0 nylon sutures were placed at the corners and the 
free margin of the rectangular scleral flap. Vitrectomy was 
subsequently done at the margins of the flap to prevent vit-
reous wick in the wound area. Following completion of the 
vitrectomy, the scleral flap was sutured to its original posi-
tion with more 9-0 nylon sutures. Balanced salt solution was 
injected into the eye via the limbal paracentesis port to adjust 
the IOP, if necessary. Cellulose sponges were used to check 
to see if the wound was watertight. If there was any leak, 
more 9-0 nylon sutures were placed. Any previously detached 
rectus muscle was sutured to its original position/insertion, 
and the conjunctiva was reapproximated to the limbus with 
7/0 vicryl sutures.
Adjunctive plaque radiotherapy with a 20 mm or 25 mm 
round Ruthenium-106 plaque was done 1 month after exo-
resection in uveal melanoma cases with predominant ciliary 
body involvement. We did not do plaque radiotherapy in 
iridociliary or iridocorneal melanomas where the epicenter 
of the tumor was in the iris with limited involvement of the 
adjacent ciliary body. We aimed to deliver an apex dose of 
100 Gy to a 1 mm depth from the inner surface of the sclera 
during plaque radiotherapy.
Results
Of 22 patients who underwent exoresection for uveal tumors 
15 were females (68.2%) and 7 were males (31.8%). The 
tumor was located in the right eye in 11 patients (50%) and in 
the left eye in 11 patients (50%). The mean age of the patients 
at the time of surgery was 45.9 years (range: 19–72 years).
The initial Snellen visual acuity ranged from hand 
motions to 10/10. On the logMAR scale, initial visual acuity 
ranged from 0–1.9 with a mean of 0.5 logMAR. The mean 
preoperative IOP was 16.3 mmHg (range: 11–34 mmHg). 
Although focal cataract and notching of the lens were noted 
in the lens overlying the tumor, none of the patients had 
significant cataracts necessitating extraction. Tumor base 
at the largest point ranged from 1.5 mm to 15.0 mm (mean: 
7.5 mm). Tumor thickness ranged from 0.9 to 7.0 mm (mean: 
3.1 mm). All tumors were pigmented. The tumor was located 
in the nasal quadrant in 10 eyes (45.5%), in the temporal 
quadrant in 7 eyes (32%), in the inferior quadrant in 4 eyes 
(18%), and in the superior quadrant in 1 eye (4.5%). The 
tumor was located in both the iris and ciliary body (iridocili-
ary) in 11 eyes (50%) (Figure 1a), in the iridocorneal angle 
in 6 eyes (27%), in the ciliary body in 3 eyes (14%), in the 
choroid and ciliary body (ciliochoroidal) in 1 eye (4.5%), 
and in the iris, ciliary body and choroid in one eye (4.5%) 
(Figure 2a) .
The tumors were excised completely in all cases (Figures 1b, 
2b, 2d, 3). Intraoperative complications included minor bleed-
ing from the resection site, which occurred in almost all cases 
and was usually limited. Vitreous loss developed in 10 of the 
20 eyes with iris and/or ciliary tumors and was treated with 
vitrectomy at the wound margins. The histopathologic diag-
nosis was uveal malignant melanoma in 16 eyes (iridocorneal 
angle melanoma in 6 eyes, iridociliary melanoma in 5 eyes, 
ciliary melanoma in 3 eyes, ciliochoroidal melanoma in 1 eye, 
iridociliochoroidal melanoma in 1 eye), iridociliary nevus in 
4 patients, and iridociliary melanocytoma in 2 patients.
Postoperative complications included cataract in 
11 patients (50%) that was not present before surgery, 
scleral thinning in 4 patients (18%) (Figure 3), nonresolv-
ing (8 weeks) vitreous hemorrhage in 2 patients (9%), 
secondary glaucoma in 2 patients (9%), hyphema in one 
patient (4.5%), iridodialysis in 1 patient (4.5%), bullous 
keratopathy in 1 patient (4.5%), and posterior synechiae Clinical Ophthalmology 2010:4 62
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in 1 patient (4.5%). All patients with cataract underwent 
phacoemulsification surgery with intraocular lens implan-
tation (IOL) (Figure 1c). In one case (4.5%), nucleus drop 
during phacoemulsification surgery occurred, necessitating 
vitrectomy and nuclear fragment removal via vitrectomy 
and phacofragmentation. One patient developed bullous 
keratopathy after PLSU and subsequent phacoemulsifica-
tion surgery. Of the four patients with scleral thinning, three 
remained stable and one underwent patch graft reinforcement 
because of bulging of the anterior uvea. Of the two patients 
with vitreous hemorrhage, one underwent vitrectomy. The 
other opted to wait, and the hemorrhage cleared partially 
in the second year after surgery. Secondary glaucoma was 
due to hyphema in one patient, and this patient underwent 
trabeculectomy. Both patients with secondary glaucoma 
needed antiglaucoma drops for IOP control. After PLSU, 
adjunctive Ru-106 plaque radiotherapy was performed in 
five cases with ciliary, ciliochoroidal, and iridociliochoroidal 
melanoma (Figure 2c).
Final Snellen visual acuity ranged from hand motions to 
10/10. Final logMAR visual acuity ranged from 0–1.9 with 
a mean of 0.5 logMAR. The mean final IOP was 16.2 mmHg 
(range: 10–30 mmHg). We did not observe any recurrence 
in any patient during the follow-up period, which ranged 
from 1–98 months (mean: 40.1 months). Systemic metas-
tasis was not seen in any patient with uveal melanoma at 
the end of the follow-up ranging from 1–98 months (mean: 
45.9 months).
Discussion
The indications for exoresection have evolved over the past 
decades. Today many surgeons perform exoresection mainly 
for iridociliary and ciliary body tumors with minimal if any 
choroidal involvement. Endoresection, on the other hand, is 
usually done after proton beam irradiation or gamma-knife 
radiosurgery in choroidal tumors located posterior to the 
equator.13 The rationale for endoresection is to preserve the 
eye from the complications of inflammation associated with 
tumor necrosis.
Certain inherent difficulties of exoresection via PLSU 
can result in intraoperative, early (occurring 8 weeks after 
surgery), and late complications (8 weeks after surgery). 
One of the major intraoperative problems is the failure to dis-
sect a scleral flap of desired thickness. It is important to find 
the right plane of dissection at the time the groove is made in 
the sclera. If the flap is not of the desired thickness initially, 
as judged by the lack of the underlying blue color of uvea, 
the plane of dissection can gently be deepened. Care should 
Figure 1a inferiorly located iridociliary melanoma.
Figure 1b After exoresection via partial lamellar sclerouvectomy and complete 
tumor removal, notching of the lens induced by the tumor and posterior subcapsular 
cataract are seen.
Figure 1c After phacoemulsification and intraocular lens placement, the patient 
achieved 20/30 vision in this eye.Clinical Ophthalmology 2010:4 63
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Figure 2b Gross photograph of the excised tumor showing a greater than 10 mm 
diameter uveal melanoma.
Figure 2c One month after exoresection, plaque radiotherapy with a 25 mm Ru-106 
plaque was applied to decrease the risk of postoperative recurrence.
Figure 2d Anterior segment view one month after partial lamellar sclerouvectomy 
showing the absence of the iris from 7 to 11 o’clock after pupillary dilation. The 
corneal pigment was left untreated.
be taken to avoid uveal perforation or vitreous loss when 
dissecting or deepening the flap, as this may significantly 
complicate the surgery.
In the senior author’s experience, the second major intra-
operative challenge is to open the choroidal slit and dissect 
the uveal tissue without damaging the underlying retina or the 
nonpigmented ciliary epithelium. The uveal tissue must be 
cauterized uniformly to decrease the chance of hemorrhage 
and facilitate the making of the incision in the uvea. When 
there is no bleeding, cutting through the uveal tissue is easier 
and safer in terms of not damaging the underlying retina and 
nonpigmented ciliary epithelium. Once a slit opening is made 
in the uvea using a knife needle, the surgeon should insert 
one blade of Vannas scissors slowly into the uveal slit, taking 
care to stay almost parallel to the plane of dissection. Any 
vertical movement of the blade may cause perforation of the 
retina or nonpigmented ciliary epithelium and vitreous loss. 
We have found that vitreous loss and subsequent vitrectomy 
did not lead to retinal detachment, as long as the tumor base 
remained anterior to the muscle insertions. We first close the 
scleral flap with 3–5 sutures and do vitrectomy at the wound 
margins subsequently. This technique is safer compared to an 
open sky vitrectomy approach because of the decreased risks 
of hypotony and possible retinal damage. Our experience with 
purely choroidal tumors was limited. Problems with retinal 
detachment may be more likely to occur in tumors located 
posterior to the muscle insertions.
Early postoperative complications include vitreous hem-
orrhage, hyphema, subretinal hemorrhage, transient blepha-
roptosis, cataract, retinal detachment, choroidal detachment, 
corneal edema, and elevated IOP.9–12 The most common early 
complication after PLSU surgery is vitreous hemorrhage.10 
Vitreous hemorrhage was reported to occur in 28 of 95 (29%) 
patients in the series by Shields and colleagues.10 It generally 
Figure 2a Massive iridociliochoroidal melanoma producing corneal touch.Clinical Ophthalmology 2010:4 64
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occurs from inadequately cauterized choroidal or ciliary body 
blood vessels.9,10 In general, vitreous hemorrhage resolves 
spontaneously; however, when it persists beyond 8 weeks, 
pars plana vitrectomy can be performed. Persistent vitreous 
hemorrhage was seen in only 2 of 22 (9%) patients in our 
series and in 3 of 95 (3%) patients in the series by Shields 
and colleagues.10
Late postoperative complications include cataract, 
preretinal fibrosis, subretinal fibrosis, posterior synechiae, 
retinal detachment, cystoid macular edema, elevated 
IOP, scleral thinning and iris neovascularization.9–12 Iatro-
genic lens damage can lead to cataract formation during 
surgery. However, often, there is a slow and progressive 
cataract development many months after surgery, occurring 
as a late complication. It is believed that if the retrolenticular 
vitreous is not disturbed, the risk of cataract decreases.9 
The senior author has found that it is important to use 
a paracentesis port rather than the main corneoscleral 
incision for purposes of injecting viscoelastic into the 
anterior chamber or inflating the eye at the end of surgery. 
This approach poses less risk of inadvertently damaging 
the lens. Eleven of 22 patients (50%) required cataract 
surgery with phacoemulsification and IOL implantation 
in our series. After PLSU, zonular defects can occur, and 
phacoemulsification surgery should be performed with 
care. Cases with more than three clock hours of zonular 
defects are more likely to be complicated; cataract surgery 
in these cases should be performed by an experienced 
phaco surgeon.14 Four (18%) of our patients had scleral 
thinning, probably indicating a flap thickness problem, as 
discussed previously. Usually, this problem can be followed 
with observation unless marked bulging of the uveal tract 
develops, in which case scleral reinforcement with a patch 
graft should be considered.
Tumor recurrence may follow incomplete removal of 
malignant tumors with positive surgical margins. To avoid 
this serious problem, adjunctive plaque radiotherapy has been 
suggested. In the series by Damato and colleagues, adjunctive 
plaque radiotherapy was shown to be effective for decreasing 
local tumor recurrence after PLSU.15 Histopathologic study of 
enucleated eyes harboring melanoma show melanoma cells in 
the sclera in 56% of cases.16 The presence of untreated intra-
scleral melanoma cells is another reason to perform plaque 
radiotherapy after PLSU.14 Kim and colleagues speculated 
that dissemination of melanoma cells during PLSU may 
account for occurrence of noncontiguous new tumor after 
surgery.17 We performed plaque radiotherapy using Ru-106 
plaques in five cases with ciliary, ciliochoroidal, and irido-
ciliochoroidal melanoma.
Distant metastasis presents a challenging problem in patients 
with uveal melanoma. In the series by Damato and colleagues, 
predictors for metastatic disease included: epithelioid/mixed 
cell type; largest basal tumor diameter 16 mm; patient age 
greater than 60 years; secondary enucleation for gross residual 
or recurrent tumor; secondary enucleation for extraocular exten-
sion; and superior tumor location.18 Memmem and McLean 
found that epithelioid/mixed tumor cell type and involvement 
of the surgical margin by the melanoma were risk factors 
for metastasis.19 In the series by Shields and colleagues, 5 of 
95 patients (7%) developed metastatic disease, whereas in the 
series by Damato and colleagues, 52 of 332 patients (15%) 
had metastatic disease.10,18 Bechrakis and colleagues and 
Augsburger and colleagues found no statistically significant 
difference in the survival rate of patients treated with PLSU 
versus those treated with plaque radiotherapy.20,21 Furthermore, 
visual outcomes appeared to be better after PLSU than after 
radiation treatment.21,22 At a mean follow up of 46 months, we 
did not record any metastasis in our series of 16 patients with 
uveal melanoma.
Our results show that the complication and recurrence 
rates at short term were comparable to the results in series 
published by experienced authors. Although the surgical 
technique poses some difficulties, exoresection seems to be 
an effective treatment option in selected cases of iridociliary 
and ciliary body tumors. In ciliary body tumors extending 
posteriorly into the choroid, separation of the retina from 
the tumor can be difficult. Therefore, it is advisable to 
limit the use of exoresection to tumors located anterior to 
the ora serrata especially for inexperienced surgeons. The 
purpose of this paper has been to describe potential surgical 
Figure 3 scleral thinning in the superonasal quadrant of an eye that underwent partial 
lamellar sclerouvectomy for an iridociliary melanoma.Clinical Ophthalmology 2010:4
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problems that might be encountered during exoresection and 
methods to avoid and/or manage them. Ocular oncologists 
with limited training in exoresection should not be reluctant 
to do this type of surgery, provided they understand the 
basic surgical principles involved and think they are able 
to do it. The surgery is inevitably associated with several 
postoperative complications requiring frequent patient 
monitoring.
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